Patent · US Expired

Method and medicament for inhibiting the expression of a given gene

US8202980B2 · kind B2 · utility

12Cited by

71References

17Claims

0Family size

Assignee

Alnylam Pharmaceuticals, Inc. · US

Inventors

Roland Kreutzer · Weidenberg, DE
Stefan Limmer · Neudrossenfeld, DE

Key dates

Filing date	Jul 2, 2003
Grant date	Jun 19, 2012
Priority date	—
Expiry date	Jul 2, 2023

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides methods and compositions for inhibiting gene expression using double stranded RNA molecules that are between 15 and 21 nucleotides in length and are complementary to a target gene sequence.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.